Skip To Main Content
Sylvain Losdat on Muck Rack

Sylvain Losdat

As seen in: JAMA (The Journal of the American Medical Association), JACC (Journal of the American College of Cardiology), International Journal of Cardiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Sylvain Losdat’s profile

Articles by Sylvain Losdat

Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy:

|
By Flavio G. Biccirè, Jonas Häner, Sylvain Losdat, Yasushi Ueki
| JACC (Journal of the American College of Cardiology)
References 1. "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials". Lancet . 2010;376:9753: 1670-1681. 2. "Alirocumab and cardiovascular outcomes after acute coronary syndrome". N Engl J Med . 2018;379:22: 2097-2107. 3. "FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease". N Engl J Med . 2017;376:18: 1713-1722. 4.
Open in Who Shared Issue with article?

Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment-elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial

|
By Juan F Iglesias, Olivier Muller Verified, CTU Bern, Sylvain Losdat
| International Journal of Cardiology Verified
Highlights • Randomized evidence comparing differential clinical outcomes between newer-generation drug-eluting stents (DES) in patients with ST-segment-elevation myocardial infarction (STEMI) undergoing multivessel percutaneous coronary intervention (PCI) is limited.
Open in Who Shared Issue with article?
Show More